-
Mashup Score: 0Seeing the Forest Through the Trees: Therapeutic Approaches for Hospitalized Patients with COVID-19 ***Expert Roundtable*** Pre-Assessment - 11 month(s) ago
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: Infectious Disease, Latest HeadlinesTweet-
4/#MedTwitter #FOAMcc #IDMedEd #Hospitalists #CME🏅➡️https://t.co/kW3SNdcfar 🟢#PreTest Q 3️⃣ 📊Which of the following correlated with more severe COVID disease? a) SARS-CoV-2 nAb b) Viral NRA <10,000 c/mL c) CRP levels >5 mg/dL d) Plasma antigen levels ≥1000 ng/L
-
3/#MedTwitter #FOAMcc #IDMedEd #Hospitalists #CME🏅➡️https://t.co/kW3SNdcfar 🟢#PreTest Q 2️⃣ 📊NIH guidelines recommend the following agents for a hospitalized patient on conventional O2 supplementation at risk for disease progression:
-
-
Mashup Score: 1
After weeks of few to no cases in the U.S., Chicago health officials warned of a “resurgence” in mpox.
Source: www.cbsnews.comCategories: Infectious Disease, Latest HeadlinesTweet-
France, some Asian countries and US reporting new mpox cases with concern that its occuring even in fully vaccinated folks. Suggests virus may be mutating for immune evasion Lets keep our eyes on this one and watch for new cases... https://t.co/ovteLlBpMt
-
-
Mashup Score: 0
-
“🏥#CrackTheCase Hospitalized Pts w/ COVID-19 – Day 1️⃣ – Best practices for mgmt of immunocompromised, critically-ill patients w/⭐️@NidaQadirMD; @WrayCharles; @DrOnyemaOgbuagu; @BonumCe https://t.co/DIPWorVMuh”
Read the original tweet here
Source: TwitterCategories: Infectious Disease, Latest HeadlinesTweet-
2/#MedTwitter #IDTwitter #IDMedEd #FOAMCC 1️⃣Answer pre-polls👇 2️⃣Watch day 1🎥https://t.co/oT1LlXwRRo 3️⃣Watch day 2📽️👆 4️⃣Claim CME 🏆https://t.co/yUGTMnfNGc Supported by an educational grant from #Gilead Sciences, Inc. 📸Faculty disclosures & CMEℹ️ https://t.co/2JSq0TtsmH
-
-
Mashup Score: 2
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: Infectious Disease, Latest HeadlinesTweet-
4/#MedTwitter #IDTwitter #IDMedEd #IDFellow #IMResident #Hospitalists #CME🔗https://t.co/Wr8JTklHa4 🔴Post-Poll 2️⃣ 🏥Hospitalized 66yo female pt 🚬Smoker 🌡w fever, cough, nausea, SOB SpO2 = 94% on room air 90 bpm pulse ➕for COVID ❓Given risk factors, what tx do you select?
-
3/#MedTwitter #IDTwitter #IDMedEd #IDFellow #IMResident #InternalMedicine #Hospitalists #CME🔗https://t.co/Wr8JTklHa4 🔴Post-Poll 1️⃣ 67yo male pt w/ COVID+ PCR has an SpO2 = 98% on room air, arthralgias, mild cough; & headache. Of the following, how would you stage this pt?
-
-
Mashup Score: 0
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: Infectious Disease, Latest HeadlinesTweet-
1/#MedTwitter #IDTwitter #IDMedEd #InternalMedicine #Hospitalists It's as easy as 1️⃣2️⃣3️⃣ 1️⃣Watch📽️👆 2️⃣Answer the post-polls🗳️👇 3️⃣Claim #CME @ https://t.co/Wr8JTklHa4 📸Faculty disclosures & #CME ℹ️👇 Supported by an independent edu grant from #Gilead https://t.co/k4Na1VUXz8
-
-
Mashup Score: 0Crack the Case #1 — Current Activities - 1 year(s) ago
This CME-certified, video reviews a patient case and the best practices for treatment and staging based on the latest clinical guidance regarding severity assessments for hospitalized patients with COVID-19.
Source: Current ActivitiesCategories: Infectious Disease, Latest HeadlinesTweet-
5/#MedTwitter #IDTwitter #IDMedEd #IDFellow #IMResident #InternalMedicine #Hospitalists #BonumCE #FOAMCC #CME🏅➡️https://t.co/DGYeVFJ53J 🟢Pre-poll Q 2️⃣ ❓For a COVID+ patient, which of the following are considered risks for disease progression?
-
4/#MedTwitter #IDTwitter #IDMedEd #IDFellow #IMResident #InternalMedicine #Hospitalists @BonumCe #CME➡️https://t.co/DGYeVFJ53J 🟢Pre-Poll1️⃣ ❓@NIH guidelines recommend which tx for pts w/ mild/moderate #COVID19 infection, no O2 supp, but who have high risk for progression?
-
3/#MedTwitter #IDTwitter #IDMedEd #IDFellow #IMResident #InternalMedicine #Hospitalists @BonumCe #CME➡️https://t.co/DGYeVFJ53J 🗳️pre-polls👇 🟢What’s your specialty?
-
2/#MedTwitter #IDTwitter #IDMedEd #InternalMedicine #Hospitalists 1️⃣Answer pre-polls👇 2️⃣Watch📽️👆 3️⃣Come back tmrw👂RE: best practices in stging & mgmt 4️⃣Claim #CME https://t.co/DGYeVFJ53J 📸Faculty disclosures & #CME ℹ️ Supported by an independent edu grant from #Gilead https://t.co/thzvTgUrcq
-
-
Mashup Score: 2COVID-19 Vaccines for Kids Under 5: What Parents Need To Know - 1 year(s) ago
Yale Medicine physicians discuss the authorization of COVID-19 vaccines for children under age 5.
Source: Yale MedicineCategories: Infectious Disease, Latest HeadlinesTweet-
Happy to announce that we (my research program @ Yale) are now initiating studies for Pfizer's bivalent COVID-19 vaccine for children ages 6 months to <5 years! (3rd and 4th doses) COVID still circulating, not over yet! Send me a "DM" if interested! https://t.co/aIkUEIkLws
-
-
Mashup Score: 1Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial | Johnson & Johnson - 1 year(s) ago
Independent, scheduled review of Phase 3 Mosaico study finds investigational vaccine regimen lacks efficacy in preventing HIVNo vaccine-related safety issues identified
Source: Content Lab U.S.Categories: Infectious Disease, Latest HeadlinesTweet-
Another HIV vaccine trial fails...this one was combo of Adenoviral vectored and adjuvanted protein vaccines. As a field, we learn from failures and celebrate successes. Waiting for mRNA vaccine early immunogenicity/ safety data this year! https://t.co/trf7k925JV
-
-
Mashup Score: 8
The race is wide open in the presidential election in Nigeria, Africa’s most populous nation and a struggling economic powerhouse. Youth looking to evict the old guard are cheering on Peter Obi, a surprise third-party candidate.
Source: www.nytimes.comCategories: Infectious Disease, Latest HeadlinesTweet-
My fellow Nigerians... I am super impressed by the "Obidient" movement. Lets vote next week for a new generation of leaders starting with the presidency! He’s Energized Nigeria’s Young Voters. Will They Turn Out for Him? https://t.co/OGSl0M1S5c
-
-
Mashup Score: 0Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis - 1 year(s) ago
Protection from past infection against re-infection from pre-omicron variants was very high and remained high even after 40 weeks. Protection was substantially lower for the omicron BA.1 variant and declined more rapidly over time than protection against previous variants. Protection from severe disease was high for all variants. The immunity conferred by past infection should be weighed…
Source: The LancetCategories: Infectious Disease, Latest HeadlinesTweet-
This is a "biggie" Past infection confers prolonged protection against severe COVID as far out as 9 months + BUT wanes over time and less protective against reinfection in the face of emerging more immune evasive variants. https://t.co/B28A8SM38K
-
5/#MedTwitter #FOAMcc #IDMedEd #Hospitalists #CME🏅➡️https://t.co/kW3SNdcfar 🟢#PreTest Q 4️⃣ 📊 What types of trials are providing timely new evidence for COVID-19 therapeutics?